Nutritional Implications of Erythropoietin Therapy in Dialysis Patients

作者: Charles J. Kaupke , N. D. Vaziri

DOI: 10.1111/J.1525-139X.1992.TB00218.X

关键词:

摘要:

参考文章(22)
McCarthy Jt, Johnson Wj, Nixon De, Moyer Tp, Jenson Bm, Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. Journal of Laboratory and Clinical Medicine. ,vol. 114, pp. 193- 199 ,(1989)
Gardner Pw, Miller Jh, Shinaberger Jh, Erythropoietin alert: risks of high hematocrit hemodialysis. Asaio Journal. ,vol. 34, pp. 179- ,(1988)
C.J. Kaupke, N.D. Vaziri, J.R. Sampson, K. Atkins, Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients. International Journal of Artificial Organs. ,vol. 13, pp. 218- 222 ,(1990) , 10.1177/039139889001300405
S.E. Bennett, M.E. Edmunds, J. Feehally, J. Walls, Nutritional Status of Hemodialysis Patients Receiving Recombinant Human Erythropoietin Therapy Journal of Renal Nutrition. ,vol. 1, pp. 125- 129 ,(1991) , 10.1016/S1051-2276(12)80004-5
Bernard Canaud, Chantal Polito-Bouloux, Laurie J. Garred, Jean-Pierre Rivory, Patrick Donnadieu, Jean Taib, Pierre Florence, Charles Mion, Recombinant Human Erythropoietin: 18 Months' Experience in Hemodialysis Patients American Journal of Kidney Diseases. ,vol. 15, pp. 169- 175 ,(1990) , 10.1016/S0272-6386(12)80515-4
S Casati, P Passerini, M R Campise, G Graziani, B Cesana, M Perisic, C Ponticelli, Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. BMJ. ,vol. 295, pp. 1017- 1020 ,(1987) , 10.1136/BMJ.295.6605.1017
David B. Van Wyck, The Challenge of Iron Deficiency during r-HuEP Therapy Seminars in Dialysis. ,vol. 2, pp. 135- 136 ,(2007) , 10.1111/J.1525-139X.1989.TB00582.X
Michael K. Hise, Pramod S. Mehta, Activity of calcium-sensitive phospholipid-dependent protein kinase C following nephron loss Kidney International. ,vol. 36, pp. 216- 221 ,(1989) , 10.1038/KI.1989.182
Bruce S. Spinowitz, Joan Arslanian, Chaim Charytan, Ronald A. Golden, Joel Rascoff, Marilyn Galler, Impact of Epoetin Beta on Dialyzer Clearance and Heparin Requirements American Journal of Kidney Diseases. ,vol. 18, pp. 668- 673 ,(1991) , 10.1016/S0272-6386(12)80607-X
David B Van Wyck, John C Stivelman, Joaquin Ruiz, Linda F Kirlin, Murray A Katz, David A Ogden, None, Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney International. ,vol. 35, pp. 712- 716 ,(1989) , 10.1038/KI.1989.43